TMCnet News

DexCom Announces Upcoming Conference Presentations
[April 30, 2014]

DexCom Announces Upcoming Conference Presentations


SAN DIEGO --(Business Wire)--

DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on DexCom at the following upcoming investor conferences:

  • Steve Pacelli, Executive Vice President, Strategy and Corporate Development, will present an update on the company at the Deutsche Bank 39th Annual Health Care Conference in Boston, Massachusetts on Wednesday, May 7, 2014 at 12:50pm (EDT). The presentation, which will occur live at The InterContinental Hotel, will be concurrently webcast.
  • Kevin Sayer, President and Chief Operating Officer, will present an update on the company at the Bank of America Merrill Lynch 2014 Health Care Conference in Las Vegas, Nevada on Wednesday, May 14, 2014 at 3:00pm (PDT). The presentation, which will occur live at Encore at Wynn Las Vegas, will be concurrently webcast.


  • The link to each webcast will be available on the DexCom website at www.dexcom.com by navigating to "About," then "Investor Relations," and then "Events and Webcasts" and will be archived there for future reference.

    About DexCom, Inc.


    DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital.

    Cautionary Statement Regarding Forward Looking Statements

    DexCom is a medical device company with a limited operating history. Successful commercialization of the company's products is subject to numerous risks and uncertainties, including a lack of acceptance in the marketplace by physicians and patients, the inability to manufacture products in commercial quantities at an acceptable cost, possible delays in the company's development programs, the inability of patients to receive reimbursement from third-party payors and inadequate financial and other resources. Certain of these risks and uncertainties, in addition to other risks, are more fully described in the company's quarterly report on Form 10-K for the fiscal year ended December 31, 2013, as filed with the Securities and Exchange Commission on February 20, 2014.


    [ Back To TMCnet.com's Homepage ]